Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on February 2, 2004

Hypertension. 2004
Published online before print February 2, 2004, doi: 10.1161/01.HYP.0000118054.86193.ce
A more recent version of this article appeared on March 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/3/533    most recent
01.HYP.0000118054.86193.cev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imig, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imig, J. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide

ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses. EDHF Involvement

John D. Imig*

From Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta.

* To whom correspondence should be addressed. E-mail: jdimig{at}mail.mcg.edu.




This article has been cited by other articles:


Home page
HypertensionHome page
H. Wang, J. L. Garvin, J. R. Falck, Y. Ren, S. S. Sankey, and O. A. Carretero
Glomerular Cytochrome P-450 and Cyclooxygenase Metabolites Regulate Efferent Arteriole Resistance
Hypertension, November 1, 2005; 46(5): 1175 - 1179.
[Abstract] [Full Text] [PDF]